Search Results

There are 10749 results for: content related to: Questions regarding frontline therapy of acute myeloid leukemia

  1. You have full text access to this Open Access content
    Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage

    Molecular Oncology

    Volume 9, Issue 2, February 2015, Pages: 409–421, Chengzhi Xie, Holly Edwards, J. Timothy Caldwell, Guan Wang, Jeffrey W. Taub, Yubin Ge

    Version of Record online : 2 OCT 2014, DOI: 10.1016/j.molonc.2014.09.008

  2. You have free access to this content
    Acute myeloid leukemia—Major progress over four decades and glimpses into the future

    American Journal of Hematology

    Volume 91, Issue 1, January 2016, Pages: 131–145, Hagop Kantarjian

    Version of Record online : 23 DEC 2015, DOI: 10.1002/ajh.24246

  3. You have full text access to this OnlineOpen article
    ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression

    Clinical and Translational Science

    Volume 9, Issue 1, February 2016, Pages: 51–59, CD Drenberg, S Hu, L Li, DR Buelow, SJ Orwick, AA Gibson, JD Schuetz, A Sparreboom and SD Baker

    Version of Record online : 4 FEB 2016, DOI: 10.1111/cts.12366

  4. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000–2013)

    Veterinary and Comparative Oncology

    Volume 15, Issue 2, June 2017, Pages: 400–410, J. Gillem, M. Giuffrida and E. Krick

    Version of Record online : 14 OCT 2015, DOI: 10.1111/vco.12176

  5. In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticles

    Journal of Applied Polymer Science

    Volume 101, Issue 4, 15 August 2006, Pages: 2320–2332, A. K. Bajpai and Jyoti Choubey

    Version of Record online : 27 MAY 2006, DOI: 10.1002/app.23761

  6. SIOP 2016 Scientific Programme+Index

    Pediatric Blood & Cancer

    Volume 63, Issue S3, November 2016, Pages: S5–S321,

    Version of Record online : 27 SEP 2016, DOI: 10.1002/pbc.26233

  7. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia

    Cancer

    Volume 123, Issue 22, November 15, 2017, Pages: 4430–4439, Elias Jabbour, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju, Naval G. Daver, Gautam Borthakur, Nitin Jain, Marina Konopleva, Zeev Estrov, Tapan M. Kadia, William G. Wierda, Courtney D. DiNardo, Mark Brandt, Susan M. O'Brien, Jorge E. Cortes and Hagop Kantarjian

    Version of Record online : 14 JUL 2017, DOI: 10.1002/cncr.30883

  8. 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts

    Pediatric Blood & Cancer

    Volume 59, Issue 6, 1 December 2012, Pages: 965–1152,

    Version of Record online : 17 SEP 2012, DOI: 10.1002/pbc.24295

  9. You have free access to this content
    Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study

    British Journal of Clinical Pharmacology

    Volume 79, Issue 4, April 2015, Pages: 685–691, Daniel Shepshelovich, Yonatan Edel, Hadar Goldvaser, Tal Dujovny, Ofir Wolach and Pia Raanani

    Version of Record online : 23 MAR 2015, DOI: 10.1111/bcp.12530

  10. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

    Intervention Review

    The Cochrane Library

    Nicole Bergner, Ina Monsef, Gerald Illerhaus, Andreas Engert and Nicole Skoetz

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD009355.pub2

  11. You have free access to this content
    Competition of drugs to serum albumin in combination therapy

    Biopolymers

    Volume 74, Issue 3, 15 June 2004, Pages: 256–262, Anna Sułkowska, Barbara Bojko, Joanna Równicka and Wiesław Sułkowski

    Version of Record online : 26 MAR 2004, DOI: 10.1002/bip.20031

  12. You have free access to this content
    Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma

    Cancer

    Volume 116, Issue 19, 1 October 2010, Pages: 4573–4579, Luigi Rigacci, Alberto Fabbri, Benedetta Puccini, Ida Chitarrelli, Annalisa Chiappella, Umberto Vitolo, Alessandro Levis, Francesco Lauria and Alberto Bosi

    Version of Record online : 19 AUG 2010, DOI: 10.1002/cncr.25216

  13. You have free access to this content
    Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

    Cancer

    Volume 113, Issue 9, 1 November 2008, Pages: 2504–2511, Gail J. Roboz, Ellen K. Ritchie, Tania Curcio, Juliette Provenzano, Rebecca Carlin, Michael Samuel, Beth Wittenberg, Madhu Mazumdar, Paul J. Christos, Susan Mathew, Sandra Allen-Bard and Eric J. Feldman

    Version of Record online : 29 SEP 2008, DOI: 10.1002/cncr.23855

  14. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia

    European Journal of Haematology

    Volume 97, Issue 3, September 2016, Pages: 239–244, Nicole Degwert, Emily Latuske, Gabi Vohwinkel, Hauke Stamm, Marianne Klokow, Carsten Bokemeyer, Walter Fiedler and Jasmin Wellbrock

    Version of Record online : 28 DEC 2015, DOI: 10.1111/ejh.12711

  15. You have free access to this content
    In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells

    Cancer

    Volume 94, Issue 10, 15 May 2002, Pages: 2653–2662, Barbara Scappini, Francesco Onida, Hagop M. Kantarjian, Li Dong, Srdan Verstovsek, Michael J. Keating and Miloslav Beran

    Version of Record online : 14 MAY 2002, DOI: 10.1002/cncr.10543

  16. You have free access to this content
    Efficacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous leukaemia

    British Journal of Haematology

    Volume 106, Issue 4, September 1999, Pages: 1013–1019, Lindauer, Domkin, Döhner, Kolb, Neubauer, Huhn, Kreiter, Koch, Huber, Aulitzky and Fischer

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01662.x

  17. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

    British Journal of Haematology

    Volume 174, Issue 6, September 2016, Pages: 899–910, Antònia Obrador-Hevia, Margalida Serra-Sitjar, José Rodríguez, Lamiae Belayachi, Leyre Bento, Marta García-Recio, Jose María Sánchez, Priam Villalonga, Antonio Gutiérrez and Silvia Fernández de Mattos

    Version of Record online : 25 MAY 2016, DOI: 10.1111/bjh.14141

  18. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia—is more better or more of the same?

    Hematological Oncology

    Volume 34, Issue 1, March 2016, Pages: 28–35, Ofir Wolach, Gilad Itchaki, Michal Bar-Natan, Moshe Yeshurun, Ron Ram, Corina Herscovici, Ofer Shpilberg, Dan Douer, Martin S. Tallman and Pia Raanani

    Version of Record online : 17 FEB 2015, DOI: 10.1002/hon.2191

  19. You have free access to this content
    Progress in the treatment of acute myeloid leukemia

    Cancer

    Volume 110, Issue 9, 1 November 2007, Pages: 1900–1910, Farhad Ravandi, Alan K. Burnett, Edward D. Agura and Hagop M. Kantarjian

    Version of Record online : 4 SEP 2007, DOI: 10.1002/cncr.23000

  20. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group

    Pediatric Blood & Cancer

    Volume 62, Issue 7, July 2015, Pages: 1184–1189, Tamara P. Miller, Andrea B. Troxel, Yimei Li, Yuan-Shung Huang, Todd A. Alonzo, Robert B. Gerbing, Matt Hall, Kari Torp, Brian T. Fisher, Rochelle Bagatell, Alix E. Seif, Lillian Sung, Alan Gamis, David Rubin, Selina Luger and Richard Aplenc

    Version of Record online : 11 MAR 2015, DOI: 10.1002/pbc.25475